Stem cell culture engineering - process scale up and beyond

Biotechnology Journal

Volumn 6, Issue 11, 2011, Pages 1317-1329

  Sharma, Shikha ^a,b   Raju, Ravali ^a,b   Sui, Siguang ^a   Hu, Wei Shou ^a  

^a University of Minnesota   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Bioprocess; Cell culture; Scale up; Stem cells

Indexed keywords

ANTI-VIRAL VACCINE; BIOPROCESSES; CELL PRODUCTION; CELL PRODUCTS; CELL SOURCES; CELL-BASED; CLINICAL APPLICATION; CLINICAL TRIAL; CLINICAL USE; CONSISTENT QUALITY; EX-VIVO; LABORATORY PRACTICES; MANUFACTURING PROCESS; NON-TRADITIONAL; PHYSICAL VARIABLES; PROCESS CHEMICALS; PROCESS SCALE-UP; PRODUCT CELL; PRODUCT QUALITY; RECOMBINANT PROTEIN; REGENERATIVE MEDICINE; SCALE-UP; SIGNALING PATHWAYS; SMALL-SCALE OPERATIONS; STEM CELL RESEARCH;

BIOLOGICAL MATERIALS; ENGINEERING RESEARCH; MANUFACTURE; MEDICAL APPLICATIONS; PROCESS CONTROL; PROTEINS; STEM CELLS; VACCINES;

CELL CULTURE;

BIOMATERIAL;

ADULT STEM CELL; BIOPROCESS; CELL CULTURE; CELL DIFFERENTIATION; EMBRYONIC STEM CELL; EX VIVO STUDY; HUMAN; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; SCALE UP; STEM CELL;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL ENGINEERING; CELL PHYSIOLOGICAL PHENOMENA; CELLS, CULTURED; HUMANS; MODELS, ANIMAL; REGENERATIVE MEDICINE; STEM CELLS;

EID: 80855123919     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201000435     Document Type: Review

References (75)

1. Martin, G. R., Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 1981, 78, 7634-7638.
2. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A. et al., Embryonic stem cell lines derived from human blastocysts. Science 1998, 282, 1145-1147.
3. Meirelles Lda, S., Nardi, N. B., Murine marrow-derived mesenchymal stem cell: Isolation, in vitro expansion, and characterization. Br. J. Haematol. 2003, 123, 702-711.
4. Reynolds, B. A., Weiss, S., Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992, 255, 1707-1710.
5. Itzhaki-Alfia, A., Leor, J., Raanani, E., Sternik, L. et al., Patient characteristics and cell source determine the number of isolated human cardiac progenitor cells. Circulation 2009, 120, 2559-2566.
6. Stappenbeck, T. S., Miyoshi, H., The role of stromal stem cells in tissue regeneration and wound repair. Science 2009, 324, 1666-1669.
7. Discher, D. E., Mooney, D. J., Zandstra, P. W., Growth factors, matrices, and forces combine and control stem cells. Science 2009, 324, 1673-1677.
8. Krause, D. S., Theise, N. D., Collector, M. I., Henegariu, O. et al., Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001, 105, 369-377.
9. Lagasse, E., Connors, H., Al-Dhalimy, M., Reitsma, M. et al., Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. 2000, 6, 1229-1234.
10. Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126, 663-676.
11. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M. et al., Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131, 861-872.
12. Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J. et al., Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318, 1917-1920.
13. Leeper, N. J., Hunter, A. L., Cooke, J. P., Stem cell therapy for vascular regeneration: Adult, embryonic, and induced pluripotent stem cells. Circulation 2010, 122, 517-526.
14. Inoue, H., Neurodegenerative disease-specific induced pluripotent stem cell research. Exp. Cell Res. 2010, 316, 2560-2564.
15. Hanna, J., Wernig, M., Markoulaki, S., Sun, C. W. et al., Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007, 318, 1920-1923.
16. Amariglio, N., Hirshberg, A., Scheithauer, B. W., Cohen, Y. et al., Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 2009, 6, e1000029.
17. Petersen, B. E., Bowen, W. C., Patrene, K. D., Mars, W. M. et al., Bone marrow as a potential source of hepatic oval cells. Science 1999, 284, 1168-1170.
18. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K. et al., Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284, 143-147.
19. Kopen, G. C., Prockop, D. J., Phinney, D. G., Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc. Natl. Acad. Sci. USA 1999, 96, 10711-10716.
20. Uccelli, A., Moretta, L., Pistoia, V., Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 2008, 8, 726-736.
21. Boyle, A. J., McNiece, I. K., Hare, J. M., Mesenchymal stem cell therapy for cardiac repair. Methods Mol. Biol. 2010, 660, 65-84.
22. Lasala, G. P., Silva, J. A., Kusnick, B. A., Minguell, J. J., Combination stem cell therapy for the treatment of medically refractory coronary ischemia: A phase I study. Cardiovasc. Revasc. Med. 2011, 12, 29-34.
23. Lasala, G. P., Silva, J. A., Gardner, P. A., Minguell, J. J., Combination stem cell therapy for the treatment of severe limb ischemia: Safety and efficacy analysis. Angiology 2010, 61, 551-556.
24. Nistor, G. I., Totoiu, M. O., Haque, N., Carpenter, M. K., Keirstead, H. S., Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 2005, 49, 385-396.
25. Zhang, Y. W., Denham, J., Thies, R. S., Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors. Stem Cells Dev. 2006, 15, 943-952.
26. Lu, B., Malcuit, C., Wang, S., Girman, S. et al., Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells 2009, 27, 2126-2135.
27. Ballet, F., Hepatotoxicity in drug development: Detection, significance and solutions. J. Hepatol. 1997, 26 2, 26-36.
28. Rodriguez, B., Burrage, K., Gavaghan, D., Grau, V. et al., The systems biology approach to drug development: Application to toxicity assessment of cardiac drugs. Clin. Pharmacol. Ther. Ser. 2010, 88, 130-134.
29. Ebert, A. D., Yu, J., Rose, F. F. Jr., Mattis, V. B. et al., Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009, 457, 277-280.
30. Lee, G., Papapetrou, E. P., Kim, H., Chambers, S. M. et al., Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 2009, 461, 402-406.
31. Gómez-Lechón, M. J., Donato, M. T., Castell, J. V., Jover, R., Human hepatocytes as a tool for studying toxicity and drug metabolism. Curr. Drug Metab. 2003, 4, 292-312.
32. Sartipy, P., Bjorquist, P., Strehl, R., Hyllner, J., Pluripotent human stem cells as novel tools in drug discovery and toxicity testing. IDrugs 2006, 9, 702-705.
33. Baxter, M. A., Rowe, C., Alder, J., Harrison, S. et al., Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening. Stem Cell Res. 2010, 5, 4-22.
34. Kiskinis, E., Eggan, K., Progress toward the clinical application of patient-specific pluripotent stem cells. J. Clin. Invest. 2010, 120, 51-59.
35. Patel, S. A., King, C. C., Lim, P. K., Habiba, U. et al., Personalizing stem cell research and therapy: The arduous road ahead or missed opportunity? Curr. Pharmacogenomics Pers. Med. 2010, 8, 25-36.
36. Drukker, M., Katz, G., Urbach, A., Schuldiner, M. et al., Characterization of the expression of MHC proteins in human embryonic stem cells. Proc. Natl. Acad. Sci. USA 2002, 99, 9864-9869.
37. Wu, D. C., Boyd, A. S., Wood, K. J., Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack. Stem Cells 2008, 26, 1939-1950.
38. Preynat-Seauve, O., de Rham, C., Tirefort, D., Ferrari-Lacraz, S. et al., Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells. J. Cell. Mol. Med. 2009, 13, 3556-3569.
39. Abu-Absi, S. F., Seth, G., Narayanan, R. A., Groehler, K. et al., Characterization of a hollow fiber bioartificial liver device. Artif. Organs 2005, 29, 419-422.
40. Beck, J., Angus, R., Madsen, B., Britt, D. et al., Islet encapsulation: Strategies to enhance islet cell functions. Tissue Eng. 2007, 13, 589-599.
41. Carpentier, B., Gautier, A., Legallais, C., Artificial and bioartificial liver devices: Present and future. Gut 2009, 58, 1690-1702.
42. Sarver, J. G., Fournier, R. L., Numerical investigation of a novel spiral wound membrane sandwich design for an implantable bioartificial pancreas. Comput. Biol. Med. 1990, 20, 105-119.
43. van Noort, D., Ong, S. M., Zhang, C., Zhang, S. et al., Stem cells in microfluidics. Biotechnol. Prog. 2009, 25, 52-60.
44. Toh, Y. C., Zhang, C., Zhang, J., Khong, Y. M. et al., A novel 3D mammalian cell perfusion-culture system in microfluidic channels. Lab Chip 2007, 7, 302-309.
45. Emamaullee, J. A., Shapiro, A. M., Factors influencing the loss of beta-cell mass in islet transplantation. Cell Transplant. 2007, 16, 1-8.
46. Zweigerdt, R., Large scale production of stem cells and their derivatives. Adv. Biochem. Eng. Biotechnol. 2009, 114, 201-235.
47. Hare, J. M., Traverse, J. H., Henry, T. D., Dib, N. et al., A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 2009, 54, 2277-2286.
48. Kirouac, D. C., Zandstra, P. W., The systematic production of cells for cell therapies. Cell Stem Cell 2008, 3, 369-381.
49. Wlaschin, K. F., Hu, W. S., Fedbatch culture and dynamic nutrient feeding. Adv. Biochem. Eng. Biotechnol. 2006, 101, 43-74.
50. Lin, S., Talbot, P., Methods for culturing mouse and human embryonic stem cells. Methods Mol. Biol. 2011, 690, 31-56.
51. Ludwig, T. E., Levenstein, M. E., Jones, J. M., Berggren, W. T. et al., Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol. 2006, 24, 185-187.
52. Cameron, C. M., Hu, W. S., Kaufman, D. S., Improved development of human embryonic stem cell-derived embryoid bodies by stirred vessel cultivation. Biotechnol. Bioeng. 2006, 94, 938-948.
53. Park, Y., Subramanian, K., Verfaillie, C. M., Hu, W. S., Expansion and hepatic differentiation of rat multipotent adult progenitor cells in microcarrier suspension culture. J. Biotechnol. 2010, 150, 131-139.
54. Kehoe, D. E., Jing, D., Lock, L. T., Tzanakakis, E. S., Scalable stirred-suspension bioreactor culture of human pluripotent stem cells. Tissue Eng. Part A 2010, 16, 405-421.
55. Walker, M. R., Patel, K. K., Stappenbeck, T. S., The stem cell niche. J. Pathol. 2009, 217, 169-180.
56. Peerani, R., Zandstra, P. W., Enabling stem cell therapies through synthetic stem cell-niche engineering. J. Clin. Invest. 2010, 120, 60-70.
57. Peerani, R., Rao, B. M., Bauwens, C., Yin, T. et al., Niche-mediated control of human embryonic stem cell self-renewal and differentiation. EMBO J. 2007, 26, 4744-4755.
58. Xu, R. H., Peck, R. M., Li, D. S., Feng, X. et al., Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat. Methods 2005, 2, 185-190.
59. Meng, G., Liu, S., Li, X., Krawetz, R., Rancourt, D. E., Extracellular matrix isolated from foreskin fibroblasts supports long-term xeno-free human embryonic stem cell culture. Stem Cells Dev. 2010, 19, 547-556.
60. Burton, P., Adams, D. R., Abraham, A., Allcock, R. W. et al., Identification and characterization of small-molecule ligands that maintain pluripotency of human embryonic stem cells. Biochem. Soc. Trans. 2010, 38, 1058-1061.
61. Ying, Q. L., Wray, J., Nichols, J., Batlle-Morera, L. et al., The ground state of embryonic stem cell self-renewal. Nature 2008, 453, 519-523.
62. Gerrard, L., Rodgers, L., Cui, W., Differentiation of human embryonic stem cells to neural lineages in adherent culture by blocking bone morphogenetic protein signaling. Stem Cells 2005, 23, 1234-1241.
63. Roelandt, P., Pauwelyn, K. A., Sancho-Bru, P., Subramanian, K. et al., Human embryonic and rat adult stem cells with primitive endoderm-like phenotype can be fated to definitive endoderm, and finally hepatocyte-like cells. PLoS One 2010, 5, e12101.
64. Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V. et al., Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 2007, 25, 1015-1024.
65. Avery, S., Inniss, K., Moore, H., The regulation of self-renewal in human embryonic stem cells. Stem Cells Dev. 2006, 15, 729-740.
66. Parekkadan, B., Milwid, J. M., Mesenchymal stem cells as therapeutics. Annu. Rev. Biomed. Eng. 2010, 12, 87-117.
67. Gadue, P., Huber, T. L., Paddison, P. J., Keller, G. M., Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells. Proc. Natl. Acad. Sci. USA 2006, 103, 16806-16811.
68. Kouskoff, V., Lacaud, G., Schwantz, S., Fehling, H. J., Keller, G., Sequential development of hematopoietic and cardiac mesoderm during embryonic stem cell differentiation. Proc. Natl. Acad. Sci. USA 2005, 102, 13170-13175.
69. Klug, M. G., Soonpaa, M. H., Koh, G. Y., Field, L. J., Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J. Clin. Invest. 1996, 98, 216-224.
70. Ishizaka, S., Shiroi, A., Kanda, S., Yoshikawa, M. et al., Development of hepatocytes from ES cells after transfection with the HNF-3beta gene. FASEB J. 2002, 16, 1444-1446.
71. Billon, N., Jolicoeur, C., Ying, Q. L., Smith, A., Raff, M., Normal timing of oligodendrocyte development from genetically engineered, lineage-selectable mouse ES cells. J. Cell Sci. 2002, 115, 3657-3665.
72. Novak, A., Shtrichman, R., Germanguz, I., Segev, H. et al., Enhanced reprogramming and cardiac differentiation of human keratinocytes derived from plucked hair follicles, using a single excisable lentivirus. Cell Reprogram. 2010, 12, 665-678.
73. Soldner, F., Hockemeyer, D., Beard, C., Gao, Q. et al., Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009, 136, 964-977.
74. Sommer, C. A., Sommer, A. G., Longmire, T. A., Christodoulou, C. et al., Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector. Stem Cells 2010, 28, 64-74.
75. Choo, A. B., Tan, H. L., Ang, S. N., Fong, W. J. et al., Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1. Stem Cells 2008, 26, 1454-1463.